This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Systagenix Wound Management (US), Inc.
Systagenix Wound Management (US), Inc., a leader in advanced wound care solutions, is headquartered in the United States and operates extensively across North America. Founded in 2008, the company has established itself in the medical device industry, focusing on innovative products that enhance patient outcomes in wound healing. Systagenix is renowned for its unique portfolio of advanced wound dressings and management solutions, including the widely recognised AQUACEL® range, which combines superior moisture management with antimicrobial properties. The company’s commitment to research and development has positioned it as a trusted partner in healthcare, delivering products that meet the evolving needs of clinicians and patients alike. With a strong market presence and a reputation for quality, Systagenix continues to achieve notable milestones in the wound care sector, contributing significantly to improved healing processes and patient care standards.
DitchCarbon Score
How does Systagenix Wound Management (US), Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Systagenix Wound Management (US), Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Systagenix Wound Management (US), Inc.'s reported carbon emissions
Systagenix Wound Management (US), Inc. currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary and does not inherit emissions data from a parent organisation. In terms of climate commitments, Systagenix Wound Management (US), Inc. has not established any documented reduction targets or initiatives, nor does it participate in recognised climate pledges such as the Science Based Targets initiative (SBTi). This lack of publicly available information suggests that the company may still be in the early stages of developing its climate strategy. As a player in the healthcare sector, Systagenix is positioned within an industry increasingly focused on sustainability and carbon reduction. However, without specific emissions data or reduction commitments, it is challenging to assess their current impact or future goals in relation to climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Systagenix Wound Management (US), Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
